Nuclear receptor 4A1

From Wikipedia, the free encyclopedia
NR4A1
PBB Protein NR4A1 image.jpg
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesNR4A1, GFRP1, HMR, N10, NAK-1, NGFIB, NP10, NUR77, TR3, nuclear receptor subfamily 4 group A member 1, NH41
External IDsOMIM: 139139 MGI: 1352454 HomoloGene: 1612 GeneCards: NR4A1
Orthologs
SpeciesHumanMouse
Entrez

3164

15370

Ensembl

ENSG00000123358

ENSMUSG00000023034

UniProt

P22736

P12813

RefSeq (mRNA)

NM_001202233
NM_001202234
NM_002135
NM_173157
NM_173158

NM_010444

RefSeq (protein)

NP_034574

Location (UCSC)Chr 12: 52.02 – 52.06 MbChr 15: 101.25 – 101.27 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

The nuclear receptor 4A1 (NR4A1 for "nuclear receptor subfamily 4 group A member 1") also known as Nur77, TR3, and NGFI-B is a protein that in humans is encoded by the NR4A1 gene.[5][6]

Nuclear receptor 4A1 (NR4A1) is a member of the NR4A nuclear receptor family[7] of intracellular transcription factors.[6][8] NR4A1 is involved in cell cycle mediation, inflammation and apoptosis.[9]

Nuclear receptor 4A1 plays a key role in mediating inflammatory responses in macrophages.[9] In addition, subcellular localization of the NR4A1 protein appears to play a key role in the survival and death of cells.[10]

Expression is inducible by phytohemagglutinin in human lymphocytes and by serum stimulation of arrested fibroblasts. Translocation of the protein from the nucleus to mitochondria induces apoptosis. Multiple alternatively spliced variants, encoding the same protein, have been identified.[5]

Structure[]

The NR4A1 gene contains seven exons. An amino terminal transactivation domain is encoded in exon 2, a DNA-binding domain in exons 3 and 4, and dimerisation and ligand-binding domains is exons 5 to 7.[11]

The protein has an atypical ligand-binding domain that is unlike the classical ligand-binding domain in most nuclear receptors. The classical domain contains a ligand-receiving pocket and co-activator site, both of which are lacking in the NR4A family. Whereas most nuclear receptors have a hydrophobic surface that results in a cleft, NR4A1 has a hydrophilic surface.[7]

Cofactors interact with Nuclear receptor 4A1 at a hydrophobic region between helices 11 and 12 to modulate transcription.[7]

Function[]

Along with the two other NR4A family members, NR4A1 is expressed in macrophages following inflammatory stimuli. This process is mediated by the NF-κB (nuclear factor-kappa B) complex, a ubiquitous transcription factor involved in cellular response to stress.[9]

Nuclear receptor 4A1 can be induced by many physiological and physical stimuli. These include physiological stimuli such as "fatty acids, stress, prostaglandins, growth factors, calcium, inflammatory cytokines, peptide hormones, phorbol esters, and neurotransmitters" and physical stimuli including "magnetic fields, mechanical agitation (causing fluid shear stress), and membrane depolarization".[7] No endogenous ligands that bind to NR4A1 have yet been identified, so modulation occurs at the level of protein expression and posttranslational modification.Besides these, NR4A1 can mediate T cell function, the transcription factor NR4A1 is stably expressed at high levels in tolerant T cells. Overexpression of Nuclear receptor 4A1 inhibits effector T cell differentiation, whereas deletion of NR4A1 overcomes T cell tolerance and exaggerates effector function, as well as enhancing immunity against tumor and chronic virus. Mechanistically, NR4A1 is preferentially recruited to binding sites of the transcription factor AP-1, where it represses effector gene expression by inhibiting AP-1 function. NR4A1 binding also promotes acetylation of histone 3 at lysine 27 (H3K27ac), leading to activation of tolerance-related genes.[12]

There are several ligands that directly bind NR4A1, including , celastrol, and certain polyunsaturated fatty acids. These NR4A1 ligands bind at various NR4A1 sites and show activities that are dependent on ligand structure and cell context. These NR4A1 ligands may have relevance to treatment of cancer, metabolic disease, inflammation, and endometriosis.[13] NR4A1 may play a role in Drug-induced gingival overgrowth associated with exposure to phenytoin, nifedipine, and cyclosporine A.[14]

Biochemistry[]

Nuclear receptor 4A1 binds as a monomer or homodimer to response element NBRE[15] and as a homodimer to NurRE.[16] It is also capable of heterodimerising with COUP-TF (an orphan nuclear receptor) and retinoid X receptor (RXR) in mediating transcription in response to retinoids.[17]

The binding sites on the response elements for NR4A1, which are common to the two other members of the NR4A family, are:[7]

  • NBRE - 5’-A/TAAAGGTCA,
  • NurRE - a AAAT(G/A)(C/T)CA repeat,
  • RXR - DX, a motif.

Evolution and homology[]

Nuclear receptor 4A1 has the systematic HUGO gene symbol NR4A1. It belongs to a group of three closely related orphan receptors, the NR4A family (NR4A). The other two members are Nuclear receptor 4A2 (NR4A2) and Nuclear receptor 4A3 (NR4A3).

Nuclear receptor 4A1 has a high degree of structural similarity with other family members at the DNA-binding domain with 91-95% sequence conservation. The C-terminal ligand-binding domain is conserved to a lesser extent at 60% and the N-terminal AB region is not conserved, differing in each member.[7]

The three members are similar in biochemistry and function. They are immediate early genes activated in a ligand-independent manner that bind at the homologous sites on response elements.[11]

Nuclear receptor 4A1 and the rest of the NR4A family are structurally similar to other nuclear receptor superfamily members, but contain an extra intron. The DNA-binding domain at exons 3 and 4 of the NR4A1 gene is conserved among all members of the nuclear receptor.[11]

NR4A1 has homologous genes in a range of species including neuronal growth factor-induced clone B in rats, Nur77 in mice and TR3 in humans.[18]

Pathology[]

Along with 16 other genes, NR4A1 is a signature gene in the metastasis of some primary solid tumours. It is downregulated in this process.[19]

Interactions[]

Nuclear receptor 4A1 has been shown to interact with:

References[]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000123358 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000023034 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: NR4A1 nuclear receptor subfamily 4, group A, member 1".
  6. ^ a b Chang C, Kokontis J, Liao SS, Chang Y (1989). "Isolation and characterization of human TR3 receptor: a member of steroid receptor superfamily". J. Steroid Biochem. 34 (1–6): 391–5. doi:10.1016/0022-4731(89)90114-3. PMID 2626032.
  7. ^ a b c d e f Maxwell MA, Muscat GE (2006). "The NR4A subgroup: immediate early response genes with pleiotropic physiological roles". Nucl Recept Signal. 4: e002. doi:10.1621/nrs.04002. PMC 1402209. PMID 16604165.
  8. ^ Milbrandt J (1988). "Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene". Neuron. 1 (3): 183–8. doi:10.1016/0896-6273(88)90138-9. PMID 3272167. S2CID 41639878.
  9. ^ a b c Pei L, Castrillo A, Tontonoz P (2006). "Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77". Mol. Endocrinol. 20 (4): 786–94. doi:10.1210/me.2005-0331. PMID 16339277.
  10. ^ Zhang XK (2007). "Targeting Nur77 translocation". Expert Opin. Ther. Targets. 11 (1): 69–79. doi:10.1517/14728222.11.1.69. PMID 17150035. S2CID 2217539.
  11. ^ a b c Saucedo-Cardenas O, Kardon R, Ediger TR, Lydon JP, Conneely OM (1997). "Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor, NURR1". Gene. 187 (1): 135–9. doi:10.1016/S0378-1119(96)00736-6. PMID 9073077.
  12. ^ Liu X, Wang Y, Lu H, Li J, Yan X, Xiao M, et al. (March 2019). "Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction". Nature. 567 (7749): 525–529. Bibcode:2019Natur.567..525L. doi:10.1038/s41586-019-0979-8. PMC 6507425. PMID 30814730.
  13. ^ Safe, Stephen; Shrestha, Rupesh; Mohankumar, Kumaravel (7 June 2021). "Orphan nuclear receptor 4A1 (NR4A1) and novel ligands". Essays in Biochemistry: EBC20200164. doi:10.1042/EBC20200164. PMID 34096590. S2CID 235360253.
  14. ^ Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi (July 2021). "The role of nuclear receptor 4A1 (NR4A1) in drug‐induced gingival overgrowth". The FASEB Journal. 35 (7). doi:10.1096/fj.202100032R.
  15. ^ Hiromura M, Suizu F, Narita M, Kinowaki K, Noguchi M (2006). "Identification of nerve growth factor-responsive element of the TCL1 promoter as a novel negative regulatory element". J. Biol. Chem. 281 (38): 27753–64. doi:10.1074/jbc.M602420200. PMID 16835233.
  16. ^ Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P, Drouin J (1997). "Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells". Mol. Cell. Biol. 17 (10): 5946–51. doi:10.1128/MCB.17.10.5946. PMC 232442. PMID 9315652.
  17. ^ Han YH, Cao X, Lin B, Lin F, Kolluri SK, Stebbins J, Reed JC, Dawson MI, Zhang XK (2006). "Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt". Oncogene. 25 (21): 2974–86. doi:10.1038/sj.onc.1209358. PMID 16434970.
  18. ^ Wei T, Geiser AG, Qian HR, Su C, Helvering LM, Kulkarini NH, Shou J, N'Cho M, Bryant HU, Onyia JE (2007). "DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids". BMC Women's Health. 7: 5. doi:10.1186/1472-6874-7-5. PMC 1852551. PMID 17407572.
  19. ^ Ramaswamy S, Ross KN, Lander ES, Golub TR (2003). "A molecular signature of metastasis in primary solid tumors". Nat. Genet. 33 (1): 49–54. doi:10.1038/ng1060. PMID 12469122. S2CID 12059602.
  20. ^ Pekarsky Y, Hallas C, Palamarchuk A, Koval A, Bullrich F, Hirata Y, Bichi R, Letofsky J, Croce CM (March 2001). "Akt phosphorylates and regulates the orphan nuclear receptor Nur77". Proc. Natl. Acad. Sci. U.S.A. 98 (7): 3690–4. Bibcode:2001PNAS...98.3690P. doi:10.1073/pnas.051003198. PMC 31113. PMID 11274386.
  21. ^ a b Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X, Dawson MI, Reed JC, Zhang XK (February 2004). "Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3". Cell. 116 (4): 527–40. doi:10.1016/S0092-8674(04)00162-X. PMID 14980220.
  22. ^ a b Kim BY, Kim H, Cho EJ, Youn HD (February 2008). "Nur77 upregulates HIF-α by inhibiting pVHL-mediated degradation". Experimental & Molecular Medicine. 40 (1): 71–83. doi:10.3858/emm.2008.40.1.71. PMC 2679322. PMID 18305400.
  23. ^ Sohn YC, Kwak E, Na Y, Lee JW, Lee SK (November 2001). "Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77". J. Biol. Chem. 276 (47): 43734–9. doi:10.1074/jbc.M107208200. PMID 11559707.
  24. ^ Wu WS, Xu ZX, Ran R, Meng F, Chang KS (May 2002). "Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions". Oncogene. 21 (24): 3925–33. doi:10.1038/sj.onc.1205491. PMID 12032831.

Further reading[]

External links[]

Retrieved from ""